Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
9°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by StageZero Life Sciences Ltd
StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting
June 28, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Resignation of CFO
May 26, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA
May 25, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update
May 17, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Launches COC Plus Worldwide
May 15, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17
May 13, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences, Ltd Announces Corporate Update
April 06, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational Update
April 01, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Launches AVRT(TM) in the UK
March 31, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Friday April 1
March 29, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in Europe
March 14, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Availability of COC Protocol in Europe
March 14, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Warrant Extension
February 04, 2022
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Formation of Scientific Advisory Board
December 14, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Named a COVID-19 Travel Testing Partner for Aruba
December 13, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences, Ltd Announces Appointment of SRCO as Auditors
December 10, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences, Ltd Announces Results of Special Meeting
December 10, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Offers BORDERPASS(TM) COVID-19 PCR Test Kits for Travelers
December 06, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Closing of CAD$4.2 Million Private Placement with Institutional Investors
November 26, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
TSX:SZLS
StageZero Life Sciences Announces CAD$4.2 Million Private Placement with Institutional Investors
November 23, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
TSX:SZLS
StageZero Life Sciences ARISTOTLE(R) Multi-Cancer Blood Test Now Available in Greater Toronto Area
November 22, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Introduces BORDERPASS(TM) COVID-19 PCR Testing for Travelers
November 19, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Q3 2021 Financial Results
November 16, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences and Teen Cancer America Join Forces to Help Improve Outcomes for Adolescents and Young Adults with Cancer
November 11, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Corporate Update
November 09, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero to Issue Q3 2021 Financial Results and Hold Conference Call on Tuesday, November 16
November 09, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Establishes On-Site Clinic for its Next-Generation Multi-Cancer Blood Test Aristotle(TM) in Richmond, Virginia
October 07, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Exposures
COVID-19
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Commencement of Trading on the OTCQB
September 27, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Completes Acquisition of the Health Clinics Business
September 02, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
SZLSF
TSX:SZLS
StageZero Life Sciences Announces Q2 2021 Financial Results and Operational Update
August 17, 2021
From
StageZero Life Sciences Ltd
Via
AccessWire
Tickers
TSX:SZLS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
